Search by Drug Name or NDC

    NDC 76204-0026-55 Arformoterol Tartrate Inhalation Solution 15 ug/2mL Details

    Arformoterol Tartrate Inhalation Solution 15 ug/2mL

    Arformoterol Tartrate Inhalation Solution is a RESPIRATORY (INHALATION) SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ritedose Pharmaceuticals, LLC. The primary component is ARFORMOTEROL TARTRATE.

    Product Information

    NDC 76204-0026
    Product ID 76204-026_0cf362f1-2a32-f966-e063-6294a90a5871
    Associated GPIs
    GCN Sequence Number 061579
    GCN Sequence Number Description arformoterol tartrate VIAL-NEB 15MCG/2ML INHALATION
    HIC3 B6Y
    HIC3 Description BETA-ADRENERGIC AGENTS, ORALLY INHALED,LONG ACTING
    GCN 97366
    HICL Sequence Number 034087
    HICL Sequence Number Description ARFORMOTEROL TARTRATE
    Brand/Generic Generic
    Proprietary Name Arformoterol Tartrate Inhalation Solution
    Proprietary Name Suffix n/a
    Non-Proprietary Name Arformoterol Tartrate Inhalation Solution
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route RESPIRATORY (INHALATION)
    Active Ingredient Strength 15
    Active Ingredient Units ug/2mL
    Substance Name ARFORMOTEROL TARTRATE
    Labeler Name Ritedose Pharmaceuticals, LLC
    Pharmaceutical Class Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA214736
    Listing Certified Through 2024-12-31

    Package

    NDC 76204-0026-55 (76204002655)

    NDC Package Code 76204-026-55
    Billing NDC 76204002655
    Package 12 POUCH in 1 CARTON (76204-026-55) / 5 AMPULE in 1 POUCH / 2 mL in 1 AMPULE
    Marketing Start Date 2023-02-27
    NDC Exclude Flag N
    Pricing Information N/A